We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+10.35%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$5.48B
AUM Growth
+$244M
Cap. Flow
-$178M
Cap. Flow %
-3.24%
Top 10 Hldgs %
8.16%
Holding
4,138
New
948
Increased
818
Reduced
676
Closed
1,018

Sector Composition

Rank Sector Weight
1 Financials 13.14%
2 Industrials 11.82%
3 Healthcare 9.09%
4 Consumer Discretionary 7.46%
5 Technology 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEST icon
1976
PUT
Westrock Coffee
WEST
$797M
$207K ﹤0.01%
15,500
-67,600
-81% -$808K
TYO icon
1977
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$12.4M
$207K ﹤0.01%
15,403
-8,687
-36% -$117K
AILE
1978
DELISTED
iLearningEngines, Inc. Common Stock
AILE
$207K ﹤0.01%
20,600
NWL icon
1979
PUT
Newell Brands
NWL
$2.18B
$207K ﹤0.01%
15,800
+9,400
+147% +$128K
AMCIU
1980
DELISTED
AMCI Acquisition Corp II Units
AMCIU
$206K ﹤0.01%
20,643
BIDU icon
1981
PUT
Baidu
BIDU
$36.5B
$206K ﹤0.01%
+1,800
New +$184K
GOGN
1982
DELISTED
GoGreen Investments Corporation
GOGN
$206K ﹤0.01%
19,800
IQV icon
1983
CALL
IQVIA
IQV
$39.1B
$205K ﹤0.01%
1,000
-2,300
-70% -$466K
CYRX icon
1984
PUT
CryoPort
CYRX
$773M
$205K ﹤0.01%
11,800
+10,000
+556% +$211K
NSP icon
1985
PUT
Insperity
NSP
$2.06B
$204K ﹤0.01%
+1,800
New +$204K
NBHC icon
1986
National Bank Holdings
NBHC
$1.9B
$204K ﹤0.01%
+4,857
New +$210K
IDXX icon
1987
PUT
Idexx Laboratories
IDXX
$44.1B
$204K ﹤0.01%
+500
New +$194K
LYEL icon
1988
Lyell Immunopharma
LYEL
$336M
$204K ﹤0.01%
2,939
-8,112
-73% -$806K
LUXH
1989
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
$204K ﹤0.01%
1,786
+216
+14% +$24K
MCR
1990
DELISTED
MFS Charter Income Trust
MCR
$204K ﹤0.01%
+33,122
New +$211K
FERG icon
1991
CALL
Ferguson
FERG
$43.9B
$203K ﹤0.01%
+1,600
New +$186K
CMCSA icon
1992
CALL
Comcast
CMCSA
$84B
$203K ﹤0.01%
5,800
-25,900
-82% -$857K
CERE
1993
PUT
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$202K ﹤0.01%
+6,400
New +$181K
ALK icon
1994
PUT
Alaska Air
ALK
$5.27B
$202K ﹤0.01%
+4,700
New +$207K
HAYN
1995
DELISTED
Haynes International, Inc.
HAYN
$202K ﹤0.01%
+4,416
New +$207K
BPMC
1996
PUT
DELISTED
Blueprint Medicines
BPMC
$202K ﹤0.01%
+4,600
New +$221K
INSP icon
1997
CALL
Inspire Medical Systems
INSP
$1.44B
$202K ﹤0.01%
800
-7,400
-90% -$1.58M
CP icon
1998
CALL
Canadian Pacific Kansas City
CP
$77.5B
$201K ﹤0.01%
2,700
-6,200
-70% -$466K
PCVX icon
1999
PUT
Vaxcyte
PCVX
$8.08B
$201K ﹤0.01%
+4,200
New +$165K
UNM icon
2000
PUT
Unum
UNM
$13.7B
$201K ﹤0.01%
4,900
-10,200
-68% -$427K

Similar funds

Walleye Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Walleye Capital held 4,138 positions worth $5.48B, up 4.6% from $5.24B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Walleye Capital withdrew a net $178M in Q4 2022, closing 1,018 positions and reducing 676 holdings. Its most notable exit was Expand Energy Corp Class B Warrants, an estimated $191M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 13% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Walleye Capital opened a new position in State Street SPDR S&P Retail ETF worth $43.9M.

  • Walleye Capital's largest Q4 2022 buy was State Street SPDR S&P Retail ETF: 726,921 shares worth $43.9M.
  • Walleye Capital added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $98.3M increase.
  • Walleye Capital's biggest Q4 2022 reduction was Equity Residential, cutting an estimated $20.2M.
  • Walleye Capital fully exited Expand Energy Corp Class B Warrants in Q4 2022, selling an estimated $191M.
  • Walleye Capital's ten largest holdings make up 8.2% of its $5.48B portfolio in Q4 2022.
  • Walleye Capital opened 948 new positions and closed 1,018 in Q4 2022.
  • Walleye Capital's portfolio value rose 4.6% quarter-over-quarter to $5.48B.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.